Rx Websites Permitted By EU Court, But Does That Dim Hopes For Further Promotions?
This article was originally published in The Pink Sheet Daily
Executive Summary
The Court of Justice of the European Union denies a challenge to a MSD website, but the restrictive decision still emphasizes the difference between providing information and promoting medicines.
You may also be interested in...
Rasi At The EMA: Redefining Benefit/Risk As Staggered Approvals Rise
The Executive Director of the European Medicines Agency Guido Rasi’s dual goals of increasing safety and overall accountability undoubtedly will benefit patients and industry alike, but a grueling task lies ahead.
Proposal To Improve Patient Information Attracts More EU Support
Pharma is relieved as an EU parliamentary committee approves revised information-to-patients proposals
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.